Response to Hinpetch Daungsupawong et al. regarding "Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence" [0.03%]
关于Hinpetch Daungsupawong等人发表的“新冠肺炎疫情封锁期间体重变化及生活方式调整：来信”的回复
F Higuera-de-la-Tijera,F Lajud-Barquín,A Tovar-Aguilar
F Higuera-de-la-Tijera
Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review [0.03%]
胃食管反流病的临床实践管理建议——拉丁美洲专家综述
M A Valdovinos-Díaz,A Hani,C Defilippi-Guerra et al.
M A Valdovinos-Díaz et al.
Introduction and aim: Due to its elevated prevalence, complex pathophysiology, and broad spectrum of clinical manifestations, gastroesophageal reflux disease (GERD) requires precision diagnosis and treatment. The aim of t...
M A Urbina,O Melin,P Galindo et al.
M A Urbina et al.
C-reactive protein as a predictor of complicated acute cholecystitis: A cohort study [0.03%]
C反应蛋白预测复杂性急性胆囊炎的队列研究
G Renau,D Abelló,F Sabench et al.
G Renau et al.
Introduction: The Tokyo Guidelines for the severity classification of acute cholecystitis (AC) include leukocytosis as a severity classifier, without considering C-reactive protein (CRP). Our aim was to determine which of...
Should mycophenolate mofetil be first-line treatment in autoimmune hepatitis? [0.03%]
霉酚酸酯应作为自身免疫性肝炎的一线用药吗？
J A Torres-Díaz,I García-Juárez
J A Torres-Díaz
Endoscopic ultrasound-guided gastrojejunostomy for managing superior mesenteric artery syndrome: A case report with follow-up at 18 months [0.03%]
内镜超声引导胃空肠造口术治疗肠系膜上动脉综合征的病例报告及18个月随访
E Murcio-Pérez,I Bartnicki-Navarrete,J C Pintor-Belmontes et al.
E Murcio-Pérez et al.
Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence [0.03%]
一封关于新冠疫情封锁期间体重变化和生活方式调整的来信
H Daungsupawong,V Wiwanitkit
H Daungsupawong
Umbilical cutaneous metastasis as initial presentation of Sigmoid adenocarcinoma [0.03%]
结肠癌转移引起的脐部皮肤病灶
G Renau,J Domènech,A Sánchez
G Renau
Fecal microbiota transplantation through colonoscopy for the management of severe refractory irritable bowel syndrome: Preliminary results [0.03%]
内镜下粪菌移植治疗难治性严重肠易激综合征的初步研究结果
C von Muhlenbrock,P Núñez,K Herrera et al.
C von Muhlenbrock et al.
Recent studies have explored the role of the microbiota in disorders of gut-brain interaction, opening pathways for therapies, such as dietary adjustments, probiotics, and fecal microbiota transplantation (FMT). We present herein a pilot st...